Deutsche Bank’s Tenax Therapeutics TENX Stock Holding History

Deutsche Bank’s Portfolio TENX Stock Details TENX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$66.9K	Buy	35,381 +10,824	+44%	+$81.5K	﹤0.01%	3441
2026 Q2	$357K	Buy	+24,557	New	+$314K	﹤0.01%	2948
2020 Q1	–	Sell	-1	Closed	-$2K	–	4808
2019 Q4	$2K	Buy	+1	New	+$1.95K	﹤0.01%	4849
2018 Q3	–	Sell	-1	Closed	-$5K	–	5556
2018 Q2	$5K	Buy	+1	New	+$10.1K	﹤0.01%	5254
2018 Q1	–	Hold	0	–	–	–	5593
2017 Q4	–	Hold	0	–	–	–	5133
2017 Q3	–	Hold	0	–	–	–	5076
2017 Q2	–	Hold	0	–	–	–	5110
2017 Q1	–	Sell	-4	Closed	-$145K	–	5097
2016 Q4	$222K	Hold	4	–	–	﹤0.01%	3618
2016 Q3	$261K	Buy	4 +1	+33%	+$78.9K	﹤0.01%	3519
2016 Q2	$237K	Hold	3	–	–	﹤0.01%	3687
2016 Q1	$190K	Hold	3	–	–	﹤0.01%	3685
2015 Q4	$304K	Sell	3 -2	-40%	-$207K	﹤0.01%	3509
2015 Q3	$434K	Hold	5	–	–	﹤0.01%	3439
2015 Q2	$534K	Hold	5	–	–	﹤0.01%	3358
2015 Q1	$471K	Hold	5	–	–	﹤0.01%	3325
2014 Q4	$556K	Hold	5	–	–	﹤0.01%	3601
2014 Q3	$569K	Buy	+5	New	+$642K	﹤0.01%	3404

Other funds holding TENX

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

Deutsche Bank's TENX Position: Q3 2026 in Review

Deutsche Bank increased its Tenax Therapeutics (TENX) stake by 44% in Q3 2026, buying an estimated $81.5K and bringing the position to 35,381 shares worth $66.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3441.

Deutsche Bank first reported a position in TENX in Q3 2014 and has held it in 14 quarters since. The position peaked at $569K in Q3 2014. 34 funds tracked by Wall St. Rank hold TENX as of Q3 2026.

Deutsche Bank held 35,381 shares of Tenax Therapeutics worth $66.9K as of Q3 2026.
Deutsche Bank bought 10,824 Tenax Therapeutics shares in Q3 2026, an estimated $81.5K.
Tenax Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q3 2026, its #3441 holding.
Deutsche Bank first reported a position in Tenax Therapeutics in Q3 2014 and has held it in 14 quarters since.
Deutsche Bank's Tenax Therapeutics position peaked at $569K in Q3 2014.
34 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q3 2026.

Based on Deutsche Bank's 13F filing for Q3 2026, filed 6 Nov 2026.